Imricor Medical Systems Future Growth
Future criteria checks 2/6
Imricor Medical Systems is forecast to grow revenue at 88.6% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 88.6% |
| Future return on equity | -187.7% |
| Analyst coverage | Low |
| Last updated | 12 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 20 | N/A | -10 | -9 | 1 |
| 12/31/2025 | 9 | N/A | -14 | -13 | 1 |
| 12/31/2024 | 4 | N/A | -16 | -15 | 1 |
| 6/30/2024 | 1 | -20 | -15 | -15 | N/A |
| 3/31/2024 | 1 | -21 | -14 | -14 | N/A |
| 12/31/2023 | 1 | -23 | -13 | -13 | N/A |
| 9/30/2023 | 1 | -20 | -14 | -14 | N/A |
| 6/30/2023 | 0 | -17 | -14 | -14 | N/A |
| 3/31/2023 | 1 | -17 | -16 | -15 | N/A |
| 12/31/2022 | 1 | -17 | -17 | -17 | N/A |
| 9/30/2022 | 1 | -18 | -17 | -17 | N/A |
| 6/30/2022 | 1 | -20 | -17 | -17 | N/A |
| 3/31/2022 | 1 | -20 | -18 | -17 | N/A |
| 12/31/2021 | 1 | -20 | -18 | -17 | N/A |
| 9/30/2021 | 1 | -18 | -17 | -16 | N/A |
| 6/30/2021 | 1 | -17 | -16 | -15 | N/A |
| 3/31/2021 | 1 | -15 | -15 | -14 | N/A |
| 12/31/2020 | 1 | -12 | -13 | -12 | N/A |
| 9/30/2020 | 1 | -13 | -12 | -11 | N/A |
| 6/30/2020 | 1 | -14 | -10 | -9 | N/A |
| 3/31/2020 | 1 | -14 | -9 | -8 | N/A |
| 12/31/2019 | 1 | -13 | -7 | -7 | N/A |
| 9/30/2019 | 1 | -11 | -6 | -6 | N/A |
| 6/30/2019 | 0 | -8 | -6 | -5 | N/A |
| 3/31/2019 | 1 | -7 | -5 | -5 | N/A |
| 12/31/2018 | 1 | -5 | -5 | -5 | N/A |
| 12/31/2017 | 0 | -5 | N/A | -4 | N/A |
| 12/31/2016 | 1 | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if IMR's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if IMR's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if IMR's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IMR's revenue (88.6% per year) is forecast to grow faster than the Australian market (5.7% per year).
High Growth Revenue: IMR's revenue (88.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IMR is forecast to be unprofitable in 3 years.